GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (FRA:OB3) » Definitions » Gross Profit

OptiBiotix Health (FRA:OB3) Gross Profit : €0.39 Mil (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is OptiBiotix Health Gross Profit?

OptiBiotix Health's gross profit for the six months ended in Jun. 2023 was €0.18 Mil. OptiBiotix Health's gross profit for the trailing twelve months (TTM) ended in Jun. 2023 was €0.39 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. OptiBiotix Health's gross profit for the six months ended in Jun. 2023 was €0.18 Mil. OptiBiotix Health's Revenue for the six months ended in Jun. 2023 was €0.41 Mil. Therefore, OptiBiotix Health's Gross Margin % for the quarter that ended in Jun. 2023 was 44.99%.

OptiBiotix Health had a gross margin of 44.99% for the quarter that ended in Jun. 2023 => Durable competitive advantage

During the past 12 years, the highest Gross Margin % of OptiBiotix Health was 86.81%. The lowest was 49.35%. And the median was 59.52%.

Warning Sign:

OptiBiotix Health PLC gross margin has been in long-term decline. The average rate of decline per year is -8.7%.


OptiBiotix Health Gross Profit Historical Data

The historical data trend for OptiBiotix Health's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health Gross Profit Chart

OptiBiotix Health Annual Data
Trend Jul10 Jul12 Nov14 Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.40 0.97 1.32 0.28

OptiBiotix Health Semi-Annual Data
Jul12 Jan13 May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.76 0.07 0.21 0.18

Competitive Comparison of OptiBiotix Health's Gross Profit

For the Biotechnology subindustry, OptiBiotix Health's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptiBiotix Health's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's Gross Profit distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's Gross Profit falls into.



OptiBiotix Health Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

OptiBiotix Health's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )=Revenue - Cost of Goods Sold
=0.525 - 0.244
=0.28

OptiBiotix Health's Gross Profit for the quarter that ended in Jun. 2023 is calculated as

Gross Profit (Q: Jun. 2023 )=Revenue - Cost of Goods Sold
=0.409 - 0.225
=0.18

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.39 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

OptiBiotix Health's Gross Margin % for the quarter that ended in Jun. 2023 is calculated as

Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.18 / 0.409
=44.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


OptiBiotix Health  (FRA:OB3) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

OptiBiotix Health had a gross margin of 44.99% for the quarter that ended in Jun. 2023 => Durable competitive advantage


OptiBiotix Health Gross Profit Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiBiotix Health (FRA:OB3) Business Description

Traded in Other Exchanges
Address
Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.

OptiBiotix Health (FRA:OB3) Headlines

No Headlines